相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Establishment of novel monoclonal antibodies KMab-1 and MMab-1 specific for IDH2 mutations
Mika Kato Kaneko et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Disruption of Wild-Type IDH1 Suppresses D-2-Hydroxyglutarate Production in IDH1-Mutated Gliomas
Genglin Jin et al.
CANCER RESEARCH (2013)
The Potential for Isocitrate Dehydrogenase Mutations to Produce 2-Hydroxyglutarate Depends on Allele Specificity and Subcellular Compartmentalization
Patrick S. Ward et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Differential expression of basement membrane type IV collagen 2 and 6 chains as a prognostic factor in patients with extrahepatic bile duct carcinoma
Kotaro Hirashima et al.
JOURNAL OF SURGICAL ONCOLOGY (2013)
Standards of care for treatment of recurrent glioblastoma-are we there yet?
Michael Weller et al.
NEURO-ONCOLOGY (2013)
(R)-2-Hydroxyglutarate Is Sufficient to Promote Leukemogenesis and Its Effects Are Reversible
Julie-Aurore Losman et al.
SCIENCE (2013)
An Inhibitor of Mutant IDH1 Delays Growth and Promotes Differentiation of Glioma Cells
Dan Rohle et al.
SCIENCE (2013)
Targeted Inhibition of Mutant IDH2 in Leukemia Cells Induces Cellular Differentiation
Fang Wang et al.
SCIENCE (2013)
Detection of 2-Hydroxyglutarate in Formalin-Fixed Paraffin-Embedded Glioma Specimens by Gas Chromatography/Mass Spectrometry
Felix Sahm et al.
BRAIN PATHOLOGY (2012)
KIAA1549-BRAF Fusions and IDH Mutations Can Coexist in Diffuse Gliomas of Adults
Manuela Badiali et al.
BRAIN PATHOLOGY (2012)
Tumour basement membrane laminin expression predicts outcome following curative resection of pancreatic head cancer
J. A. van der Zee et al.
BRITISH JOURNAL OF CANCER (2012)
IDH1 Mutations Disrupt Blood, Brain, and Barriers
Alan H. Shih et al.
CANCER CELL (2012)
Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of Glioblastoma
Dominik Sturm et al.
CANCER CELL (2012)
IDH mutations predict longer survival and response to temozolomide in secondary glioblastoma
Qi SongTao et al.
CANCER SCIENCE (2012)
Global Profiling Strategies for Mapping Dysregulated Metabolic Pathways in Cancer
Daniel I. Benjamin et al.
CELL METABOLISM (2012)
Analysis of Tumor Metabolism Reveals Mitochondrial Glucose Oxidation in Genetically Diverse Human Glioblastomas in the Mouse Brain In Vivo
Isaac Marin-Valencia et al.
CELL METABOLISM (2012)
Targeting NADPH oxidases for the treatment of cancer and inflammation
Michael Y. Bonner et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2012)
Distinct genetic alterations in pediatric glioblastomas
Sun-ju Byeon et al.
CHILDS NERVOUS SYSTEM (2012)
IDH Mutation and Neuroglial Developmental Features Define Clinically Distinct Subclasses of Lower Grade Diffuse Astrocytic Glioma
Daniel Gorovets et al.
CLINICAL CANCER RESEARCH (2012)
D-2-hydroxyglutarate produced by mutant IDH1 perturbs collagen maturation and basement membrane function
Masato Sasaki et al.
GENES & DEVELOPMENT (2012)
2-Hydroxyglutarate concentration in serum from patients with gliomas does not correlate with IDH1/2 mutation status or tumor size
David Capper et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Isocitrate Dehydrogenase (IDH) Mutations Promote a Reversible ZEB1/MicroRNA (miR)-200-dependent Epithelial-Mesenchymal Transition (EMT)
Alexandra R. Grassian et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Cancer-associated Isocitrate Dehydrogenase Mutations Inactivate NADPH-dependent Reductive Carboxylation
Roberta Leonardi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy
Whitney B. Pope et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Molecular genetics of adult grade II gliomas: towards a comprehensive tumor classification system
Dominique Figarella-Branger et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
IDH mutations as an early and consistent marker in low-grade astrocytomas WHO grade II and their consecutive secondary high-grade gliomas
Tareq A. Juratli et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers
Stephen Yip et al.
JOURNAL OF PATHOLOGY (2012)
Isocitrate dehydrogenase mutation hot spots in acute lymphoblastic leukemia and oral cancer
Jen-Yang Tang et al.
KAOHSIUNG JOURNAL OF MEDICAL SCIENCES (2012)
IDH mutation impairs histone demethylation and results in a block to cell differentiation
Chao Lu et al.
NATURE (2012)
Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation
Peppi Koivunen et al.
NATURE (2012)
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
Sevin Turcan et al.
NATURE (2012)
2-hydroxyglutarate detection by magnetic resonance spectroscopy in subjects with IDH-mutated gliomas
Changho Choi et al.
NATURE MEDICINE (2012)
Detection of 2-hydroxyglutaric acid in vivo by proton magnetic resonance spectroscopy in U87 glioma cells overexpressing isocitrate dehydrogenase-1 mutation
Jelena Lazovic et al.
NEURO-ONCOLOGY (2012)
Detection of IDH1 mutation in the plasma of patients with glioma
Blandine Boisselier et al.
NEUROLOGY (2012)
IDH1 mutation, a genetic alteration associated with adult gliomatosis cerebri
Deepti Narasimhaiah et al.
NEUROPATHOLOGY (2012)
IDH mutation status in prostate cancer
A. F. Ghiam et al.
ONCOGENE (2012)
Identification of additional IDH mutations associated with oncometabolite R(-)-2-hydroxyglutarate production
P. S. Ward et al.
ONCOGENE (2012)
Frequent Mutation of Isocitrate Dehydrogenase (IDH)1 and IDH2 in Cholangiocarcinoma Identified Through Broad-Based Tumor Genotyping
Darrell R. Borger et al.
ONCOLOGIST (2012)
Succinate dehydrogenase (SDH) and mitochondrial driven neoplasia
Anthony J. Gill
PATHOLOGY (2012)
Correlation of IDH1 Mutation with Clinicopathologic Factors and Prognosis in Primary Glioblastoma: A Report of 118 Patients from China
Wei Yan et al.
PLOS ONE (2012)
Clonal Analysis in Recurrent Astrocytic, Oligoastrocytic and Oligodendroglial Tumors Implicates IDH1- Mutation as Common Tumor Initiating Event
Ulrike Lass et al.
PLOS ONE (2012)
Decreased 5-Hydroxymethylcytosine Is Associated with Neural Progenitor Phenotype in Normal Brain and Shorter Survival in Malignant Glioma
Brent A. Orr et al.
PLOS ONE (2012)
Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas
Yuchen Jiao et al.
ONCOTARGET (2012)
IDH1 R132H Decreases Proliferation of Glioma Cell Lines In Vitro and In Vivo
Linda B. C. Bralten et al.
ANNALS OF NEUROLOGY (2011)
Implementing multiplexed genotyping of non-small-cell lung cancers into routine clinical practice
L. V. Sequist et al.
ANNALS OF ONCOLOGY (2011)
Establishment of a novel monoclonal antibody SMab-1 specific for IDH1-R132S mutation
Mika Kato Kaneko et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Biochemical characterization of human HIF hydroxylases using HIF protein substrates that contain all three hydroxylation sites
Melissa B. Pappalardi et al.
BIOCHEMICAL JOURNAL (2011)
Gene mutation patterns and their prognostic impact in a cohort of 1185 patients with acute myeloid leukemia
Yang Shen et al.
BLOOD (2011)
CBL, CBLB, TET2, ASXL1, and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia
Hideki Makishima et al.
BLOOD (2011)
Detection of IDH1 mutation in human gliomas: comparison of immunohistochemistry and sequencing
Shingo Takano et al.
BRAIN TUMOR PATHOLOGY (2011)
Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases
Wei Xu et al.
CANCER CELL (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Molecular Markers in Low-Grade Gliomas: Predictive or Prognostic?
Christian Hartmann et al.
CLINICAL CANCER RESEARCH (2011)
The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases
Rasheduzzaman Chowdhury et al.
EMBO REPORTS (2011)
IDH1 mutations in gliomas: First series from a tertiary care centre in India with comprehensive review of literature
Prerana Jha et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2011)
Cross talk between mitochondria and NADPH oxidases
Sergey Dikalov
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Isocitrate Dehydrogenase Mutations: A Challenge to Traditional Views on the Genesis and Malignant Progression of Gliomas
Michael Weller et al.
GLIA (2011)
Evidence for Sequenced Molecular Evolution of IDH1 Mutant Glioblastoma From a Distinct Cell of Origin
Albert Lai et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Rosette-forming glioneuronal tumor: a pineal region case with IDH1 and IDH2 mutation analyses and literature review of 43 cases
Orestes E. Solis et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
IDH1 and IDH2 mutations, immunohistochemistry and associations in a series of brain tumors
Marta Mellai et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours
M. Fernanda Amary et al.
JOURNAL OF PATHOLOGY (2011)
The metabolic advantage of tumor cells
Maurice Israel et al.
MOLECULAR CANCER (2011)
Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase
Christian Frezza et al.
NATURE (2011)
Metabolism unhinged: IDH mutations in cancer
John R. Prensner et al.
NATURE MEDICINE (2011)
2-Hydroxyglutarate Production, but Not Dominant Negative Function, Is Conferred by Glioma-Derived NADP+-Dependent Isocitrate Dehydrogenase Mutations
Genglin Jin et al.
PLOS ONE (2011)
Screen for IDH1, IDH2, IDH3, D2HGDH and L2HGDH Mutations in Glioblastoma
Daniel Krell et al.
PLOS ONE (2011)
Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome
Zachary J. Reitman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Characterization of R132H Mutation-specific IDH1 Antibody Binding in Brain Tumors
David Capper et al.
BRAIN PATHOLOGY (2010)
Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma
Houtan Noushmehr et al.
CANCER CELL (2010)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Inhibition of Glutaminase Preferentially Slows Growth of Glioma Cells with Mutant IDH1
Meghan J. Seltzer et al.
CANCER RESEARCH (2010)
IDH1 and IDH2 Mutations Are Prognostic but not Predictive for Outcome in Anaplastic Oligodendroglial Tumors: A Report of the European Organization for Research and Treatment of Cancer Brain Tumor Group
Martin J. van den Bent et al.
CLINICAL CANCER RESEARCH (2010)
An Overview of L-2-Hydroxyglutarate Dehydrogenase Gene (L2HGDH) Variants: A Genotype-Phenotype Study
Marjan E. Steenweg et al.
HUMAN MUTATION (2010)
Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations
Stefan Gross et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
A Pyrosequencing-Based Assay for the Rapid Detection of IDH1 Mutations in Clinical Samples
Prashanth Setty et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2010)
Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas
Christian Hartmann et al.
ACTA NEUROPATHOLOGICA (2009)
IDH1 Mutations Are Early Events in the Development of Astrocytomas and Oligodendrogliomas
Takuya Watanabe et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
A monoclonal antibody IMab-1 specifically recognizes IDH1R132H, the most common glioma-derived mutation
Yukinari Kato et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Analysis of IDH1 and IDH2 mutations in Japanese glioma patients
Yukihiko Sonoda et al.
CANCER SCIENCE (2009)
Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomas
Marc Sanson et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Diagnostic Use of IDH1/2 Mutation Analysis in Routine Clinical Testing of Formalin-Fixed, Paraffin-Embedded Glioma Tissues
Craig Horbinski et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2009)
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Lenny Dang et al.
NATURE (2009)
IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas
Koichi Ichimura et al.
NEURO-ONCOLOGY (2009)
IDH1 and IDH2 Mutations in Gliomas
Hai Yan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Pxmp2 Is a Channel-Forming Protein in Mammalian Peroxisomal Membrane
Aare Rokka et al.
PLOS ONE (2009)
Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α
Shimin Zhao et al.
SCIENCE (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
Role of cytosolic NADP+-dependent isocitrate dehydrogenase in ischemia-reperfusion injury in mouse kidney
Jinu Kim et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
Dual compartmental localization and function of mammalian NADP+-specific isocitrate dehydrogenase in yeast
Qian Lu et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2008)
Inactivation of mitochondrial NADP+-dependent isocitrate dehydrogenase by hypochlorous acid
Sin Young Park et al.
FREE RADICAL RESEARCH (2008)
An integrated genomic analysis of human glioblastoma Multiforme
D. Williams Parsons et al.
SCIENCE (2008)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
A pyruvate cycling pathway involving cytosolic NADP-dependent isocitrate dehydrogenase regulates glucose-stimulated insulin secretion
Sarah M. Ronnebaum et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The consensus coding sequences of human breast and colorectal cancers
Tobias Sjoeblom et al.
SCIENCE (2006)
Cytosolic NADP+-dependent isocitrate dehydrogenase plays a key role in lipid metabolism
HJ Koh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Structures of human cytosolic NADP-dependent isocitrate dehydrogenase reveal a novel self-regulatory mechanism of activity
X Xu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Cytosolic NADP+-dependent isocitrate dehydrogenase status modulates oxidative damage to cells
SM Lee et al.
FREE RADICAL BIOLOGY AND MEDICINE (2002)
分享论文
